About this trial
Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephrologist) who manages their dialysis may be feasible and beneficial. This study will pilot measuring the patient's residual kidney function at the time of discharge and communicating that result to the accepting nephrologist and the patient, along with information on recommended recovery monitoring frequency and criteria for consideration of a twice-weekly hemodialysis schedule.
Eligibility criteria
Qualifiers
AKI-D (not ESKD, as determined by the clinical inpatient nephrology team)
Age ≥ 18 years
Planned for continued dialysis outside the acute hospital setting (at outpatient dialysis unit/SNF/LTACH, not planned transfer to another short-stay acute care hospital).
Disqualifiers
Pregnant
Prisoner
Unable to consent and no surrogate decision maker available
Clinical team declines to allow approach for study
Trial design
Treatments tested in this trial
- Transmission of additional AKI-D recovery information
- No additional AKI-D recovery information
Treatment groups
Sponsors and collaborators
University of California, San Francisco
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator